Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Research use only24h dispatchLot-tracked COA

VaultLabs UAE

Lab Testing & Analytical Standards

Analytical data is the only part of a supplier's claim a receiving laboratory can actually check. Catalogue copy, purity badges and a vendor's description of its own standards are assertions. A named method, a lot identifier and a dated result are evidence. This page covers the analytical layer specifically: what each field on a record does and does not establish, and where supplier analysis stops and your own incoming qualification begins. Everything in the catalogue is supplied for in vitro laboratory research only.

Specification, result, and the gap between them

Two numbers on a document can look identical and mean opposite things. A specification is the limit a lot is expected to meet — a target written before the material existed. A result is what the analysis of that particular lot reported, on a stated date, by a stated method. A listing that advertises a purity figure without saying which of the two it is has given you nothing checkable, and that ambiguity is rarely accidental.

Ask which one you are reading, get the answer in writing, and file it. The failure mode this prevents is a quiet one: a laboratory records a specification as though it were a measurement, builds an acceptance range around it, and only notices the difference when a lot sitting near the limit produces retest figures that will not reconcile with anything. By then the material has usually been aliquoted and the audit trail is already awkward. The site uses specification and out-of-specification in their ordinary analytical senses.

VaultLabs publishes per-lot COA records when a record has been uploaded for that lot. Where nothing has been published, no analytical representation is made beyond the stated product specification — a boundary written into the research use policy rather than left to whatever a support conversation happens to imply.

What an HPLC purity figure covers, and what it leaves out

High-performance liquid chromatography separates a sample and reports each component's share of the detected peak area. It is the workhorse for peptide identity and purity work because it is reproducible and inexpensive to run repeatedly. It is also narrower than most buyers assume. A purity figure describes the fraction of chromatographically detectable material under one method, on one column, at one detector setting.

What it does not report: water content, residual counter-ion such as trifluoroacetate, endotoxin, sterility, or anything the detector cannot see at the chosen wavelength. A lot can carry an excellent purity number and still be a significant fraction water by mass. Where your calculation depends on mass rather than relative peak area, water content will move your result further than the last decimal place of the purity figure ever will.

Mass spectrometry answers a different question — is this the molecule the label names — and the two methods are complements rather than substitutes. Understanding HPLC and understanding mass spectrometry go through both in more detail, including what a chromatogram can hide.

Read the method line before you read the number

A result without a method is a rumour with a decimal point. The method line should name the technique and, ideally, enough of the conditions that a disagreement between your retest and the supplier's record becomes diagnosable instead of mysterious. Two laboratories running different gradients on the same lot can legitimately report figures a point apart. Without method detail you cannot distinguish that from an error, a mislabelled vial, or a document that belongs to a different batch entirely.

Check the testing entity with the same attention. Most peptide material offered in the region is bought in and relabelled, which is not disqualifying — plenty of dependable suppliers are distributors — but it changes whose analysis you are actually reading. A company with no laboratory that describes a record as coming from "our lab" has told you something useful about its paperwork discipline, and it is not the thing it intended to tell you.

How to read a peptide COA walks the fields in order. The COA checklist is the condensed version worth keeping at the receiving bench, where the decision actually gets made.

Where supplier analysis stops and yours begins

Supplier documentation is an input to your qualification, never a substitute for it. Your acceptance criteria, your reference standard comparison, and your decision about whether a lot may enter a validated assay are yours to set and yours to defend. No record establishes fitness for a particular experiment, instrument or method, and any supplier implying otherwise is describing a responsibility it cannot carry.

In practice this means qualifying on receipt rather than on first use. Incoming inspection performed weeks after the vials went into storage cannot separate a transit problem from a storage problem, and the lot has usually been split by then. Photograph labels, reconcile identifiers, and decide the lot's status before it earns a shelf position.

Where a lot's record has not yet been published, request documentation with the order and lot reference rather than inferring anything from silence. Whether pending paperwork satisfies your receiving rules is a decision for your own QA function.

How the analytical layer fits the rest of the framework

This page is deliberately limited to methods and numbers. The operating controls that produce and release a lot are described on quality control. The record chain that connects a vial in your freezer to a filed PDF is on documentation and traceability. The lookup itself, and what a result means when it comes back empty, is on batch-verified research materials.

The published bar VaultLabs holds itself to is the Vault Standard. Put your internal vendor matrix beside it and score the gaps rather than the adjectives — including on this supplier.

Frequently asked questions

No. Analytical fields appear on a per-lot COA record when one has been uploaded for that lot. Availability is lot-specific and is not guaranteed at the moment a SKU is listed. Where nothing is published, regard the product specification as the only statement made about the material.

Not on its own. A modest figure you can tie to a named method, a dated record and a lot number on the vial is more useful than an excellent figure you cannot trace to anything. The first can be audited; the second can only be believed.

Send the lot number and your institutional requirement through request documentation or bulk inquiry. What is feasible depends on the batch and is answered case by case. VaultLabs does not operate its own laboratory and will not describe an arrangement it cannot evidence.

Put the lot into quarantine status, keep the vials, and contact support with the lot identifier, your method conditions and your result. A disagreement between two named methods is a normal analytical event; a disagreement you cannot describe in method terms is a documentation problem.

No. The catalogue is supplied strictly for in vitro laboratory research by qualified personnel. It is not for human or animal consumption, clinical application, or diagnostic use of any kind.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.